Table 1 Clinical characteristics of the endometrial cancer patients (TCGA)
Characteristics | Low expression of TTK | High expression of TTK | P value |
|---|---|---|---|
n | 277 | 277 | Â |
Clinical stage, n (%) | Â | Â | < 0.001 |
Stage I | 194 (35%) | 149 (26.9%) | Â |
Stage II | 24 (4.3%) | 28 (5.1%) | Â |
Stage III | 49 (8.8%) | 81 (14.6%) | Â |
Stage IV | 10 (1.8%) | 19 (3.4%) | Â |
Age, n (%) | Â | Â | 0.010 |
<= 60 | 118 (21.4%) | 89 (16.2%) | Â |
> 60 | 157 (28.5%) | 187 (33.9%) | Â |
BMI, n (%) | Â | Â | 0.108 |
<= 30 | 98 (18.8%) | 114 (21.9%) | Â |
> 30 | 165 (31.7%) | 144 (27.6%) | Â |
Histological type, n (%) | Â | Â | < 0.001 |
Endometrioid | 243 (43.9%) | 169 (30.5%) | Â |
Mixed | 9 (1.6%) | 15 (2.7%) | Â |
Serous | 25 (4.5%) | 93 (16.8%) | Â |
Histologic grade, n (%) | Â | Â | < 0.001 |
G1 | 80 (14.7%) | 19 (3.5%) | Â |
G2 | 85 (15.7%) | 36 (6.6%) | Â |
G3 | 109 (20.1%) | 214 (39.4%) | Â |
Tumor invasion(%), n (%) | Â | Â | 0.027 |
< 50 | 154 (32.4%) | 107 (22.5%) | Â |
>= 50 | 105 (22.1%) | 110 (23.1%) | Â |
Menopause status, n (%) | Â | Â | 0.209 |
Pre | 21 (4.1%) | 14 (2.8%) | Â |
Peri | 11 (2.2%) | 6 (1.2%) | Â |
Post | 222 (43.8%) | 233 (46%) | Â |
Diabetes, n (%) | Â | Â | 0.917 |
No | 168 (37.1%) | 161 (35.5%) | Â |
Yes | 64 (14.1%) | 60 (13.2%) | Â |